← FDA Drug Approvals (Drugs@FDA)

DEXLANSOPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2024-01-19

Drug application

FDA Application #

ANDA205205

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEXLANSOPRAZOLE

Generic name

DEXLANSOPRAZOLE

Active ingredients

DEXLANSOPRAZOLE

Dosage form

CAPSULE, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2024-01-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown